ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HTFL vs LLY // OPERATING MARGIN

Heartflow Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: HTFL 3 — LLY 11
▲ OPERATING MARGIN LEADER: LLY
operating-margins
-36.40%
operating-margins
40.21%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HTFL VS. LLY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HTFL LLY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.80% 83.64% -6.84 LLY /gross-margins <GO>
Return on Invested Capital (ROIC) -12.00% 32.36% -44.36 LLY /roic <GO>
EV/EBITDA & P/E Valuation — 36.4x — TIE /valuation <GO>
Free Cash Flow Yield -1.12% 2.30% -3.42 LLY /fcf-yield <GO>
Operating Margin ACTIVE -36.40% 40.21% -76.61 LLY /operating-margins <GO>
Net Profit Margin -60.00% 31.90% -91.90 LLY /net-margins <GO>
Revenue Growth (YoY) 39.90% 45.51% -5.61 LLY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.49% -0.49 LLY /dividend-safety <GO>
Altman Z-Score & Debt/Equity 26.00 9.29 +16.71 HTFL /balance-sheet <GO>
Piotroski F-Score Quality 5/9 9/9 -4.00 LLY /piotroski-score <GO>
Options Implied Move & Put/Call Skew 6.60% 6.77% -0.17 HTFL /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 67.3 77.9 -10.57 LLY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 0.51 +0.39 HTFL /macro-sensitivity <GO>
Forward P/E Multiple 27.0x 26.3x +0.75 LLY /forward-pe <GO>
Enterprise Scale & Market Cap $5.26B $1.33T -$1.33T LLY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HTFL REV LLY REV HTFL GROSS % LLY GROSS % HTFL FCF LLY FCF
FY 2025 $176.0M $65.18B 76.8% 83.0% -$59.0M $16.81B
FY 2024 $125.8M $45.04B 75.1% 81.3% -$73.4M $8.82B
FY 2023 $87.2M $34.12B 44.0% 79.3% -$80.4M $4.24B
FY 2022 — $28.54B — 76.8% — $7.59B
FY 2021 — $28.32B — 74.2% — $7.37B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HTFL // BETA 0.90
LLY // BETA 0.51